NeuroPace (NPCE) is scheduled to report Q3 earnings on November 3, 2026. Analysts estimate EPS of $-0.07 and quarterly revenue of $27M.
In the most recent quarter (Q2), NeuroPace reported EPS of $-0.18, beating estimates of $-0.19 by 0.05%. Revenue came in at $22.83M, exceeding the estimate of $22.66M by 0.01%.
NeuroPace has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, NeuroPace has averaged an EPS surprise of 0.27% and a revenue surprise of 0.05%.
Earnings Date
Nov 3
EPS Estimate
$-0.070
Quarterly Revenue Estimate
$27M
Annual Revenue
$106.99M
as of Jun 30
Analyze the earnings history of NeuroPace using advanced sorting and filters.
The chart below shows NeuroPace's reported EPS compared to analyst estimates over recent quarters.
The chart below shows NeuroPace's reported revenue compared to analyst estimates over recent quarters.
NeuroPace (NPCE) is scheduled to report earnings on November 3, 2026. The last reported earnings were for reported on August 11, 2026 for Q2.
The Actual EPS was $-0.18, which beat the estimate of $-0.19.
The Actual Revenue was $22.83M, which beat the estimate of $22.66M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.18 | $-0.19 | 5.26 % |
| Q1 | May 12, 2026 | $-0.20 | $-0.22 | 9.09 % |
| Q4 | Mar 3, 2026 | $-0.08 | $-0.15 | 46.7 % |
| Q3 | Nov 4, 2025 | $-0.11 | $-0.20 | 45.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $22.83M | $22.66M | 0.72 % |
| Q1 | May 12, 2026 | $22.07M | $21.64M | 1.96 % |
| Q4 | Mar 3, 2026 | $26.59M | $25.25M | 5.28 % |
| Q3 | Nov 4, 2025 | $27.35M | $24.60M | 11.2 % |